BXRX Annual CFO
-$27.79 M
+$21.48 M+43.59%
31 December 2022
Summary:
As of February 5, 2025, BXRX annual cash flow from operations is -$27.79 million, with the most recent change of +$21.48 million (+43.59%) on December 31, 2022. During the last 3 years, it has risen by +$22.25 million (+44.46%).BXRX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BXRX Quarterly CFO
-$2.41 M
+$1.03 M+29.98%
01 September 2023
Summary:
As of February 5, 2025, BXRX quarterly cash flow from operations is -$2.41 million, with the most recent change of +$1.03 million (+29.98%) on September 1, 2023. Over the past year, it has increased by +$1.48 million (+37.94%).BXRX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BXRX TTM CFO
-$14.31 M
+$1.48 M+9.35%
01 September 2023
Summary:
As of February 5, 2025, BXRX TTM cash flow from operations is -$14.31 million, with the most recent change of +$1.48 million (+9.35%) on September 1, 2023. Over the past year, it has increased by +$22.35 million (+60.97%).BXRX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BXRX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.6% | +37.9% | +61.0% |
| 3 y3 years | +44.5% | +79.6% | +61.7% |
| 5 y5 years | +35.8% | - | +71.4% |
BXRX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | at high | at high |
Baudax Bio Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$2.41 M(-30.0%) | -$14.31 M(-9.3%) |
| June 2023 | - | -$3.45 M(-26.1%) | -$15.78 M(-19.3%) |
| Mar 2023 | - | -$4.66 M(+23.3%) | -$19.55 M(-29.6%) |
| Dec 2022 | -$27.79 M(-43.6%) | -$3.78 M(-2.7%) | -$27.79 M(-24.2%) |
| Sept 2022 | - | -$3.89 M(-46.1%) | -$36.66 M(-19.1%) |
| June 2022 | - | -$7.22 M(-44.1%) | -$45.34 M(-5.9%) |
| Mar 2022 | - | -$12.90 M(+2.0%) | -$48.17 M(-2.2%) |
| Dec 2021 | -$49.27 M | -$12.65 M(+0.6%) | -$49.27 M(-3.9%) |
| Sept 2021 | - | -$12.57 M(+25.0%) | -$51.26 M(+1.5%) |
| June 2021 | - | -$10.05 M(-28.2%) | -$50.49 M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$14.01 M(-4.3%) | -$51.75 M(+17.5%) |
| Dec 2020 | -$44.06 M(-12.0%) | -$14.63 M(+23.9%) | -$44.06 M(+17.9%) |
| Sept 2020 | - | -$11.80 M(+4.4%) | -$37.37 M(+31.1%) |
| June 2020 | - | -$11.31 M(+79.1%) | -$28.51 M(-32.0%) |
| Mar 2020 | - | -$6.31 M(-20.5%) | -$41.90 M(-16.3%) |
| Dec 2019 | -$50.04 M(-16.2%) | -$7.94 M(+169.5%) | -$50.04 M(+18.9%) |
| Sept 2019 | - | -$2.95 M(-88.1%) | -$42.10 M(+7.5%) |
| June 2019 | - | -$24.70 M(+70.8%) | -$39.16 M(+170.8%) |
| Mar 2019 | - | -$14.46 M | -$14.46 M |
| Dec 2018 | -$59.75 M(+38.1%) | - | - |
| Dec 2017 | -$43.27 M | - | - |
FAQ
- What is Baudax Bio annual cash flow from operations?
- What is the all time high annual CFO for Baudax Bio?
- What is Baudax Bio annual CFO year-on-year change?
- What is Baudax Bio quarterly cash flow from operations?
- What is the all time high quarterly CFO for Baudax Bio?
- What is Baudax Bio quarterly CFO year-on-year change?
- What is Baudax Bio TTM cash flow from operations?
- What is the all time high TTM CFO for Baudax Bio?
- What is Baudax Bio TTM CFO year-on-year change?
What is Baudax Bio annual cash flow from operations?
The current annual CFO of BXRX is -$27.79 M
What is the all time high annual CFO for Baudax Bio?
Baudax Bio all-time high annual cash flow from operations is -$27.79 M
What is Baudax Bio annual CFO year-on-year change?
Over the past year, BXRX annual cash flow from operations has changed by +$21.48 M (+43.59%)
What is Baudax Bio quarterly cash flow from operations?
The current quarterly CFO of BXRX is -$2.41 M
What is the all time high quarterly CFO for Baudax Bio?
Baudax Bio all-time high quarterly cash flow from operations is -$2.41 M
What is Baudax Bio quarterly CFO year-on-year change?
Over the past year, BXRX quarterly cash flow from operations has changed by +$1.48 M (+37.94%)
What is Baudax Bio TTM cash flow from operations?
The current TTM CFO of BXRX is -$14.31 M
What is the all time high TTM CFO for Baudax Bio?
Baudax Bio all-time high TTM cash flow from operations is -$14.31 M
What is Baudax Bio TTM CFO year-on-year change?
Over the past year, BXRX TTM cash flow from operations has changed by +$22.35 M (+60.97%)